M&A

Amarin for $20B? Novartis' MedCo deal drives fresh buyout rumors for Vascepa's maker
Fierce Pharma
Mon, 11/25/19 - 09:49 pm
Amarin
M&A
Novartis
Medicines Company
Gilead Sciences
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
Endpoints
Mon, 11/25/19 - 09:47 pm
Mark Timney
Purdue Pharma
Novartis
Medicines Company
M&A
Novartis buys Medicines Co. in $9.7B bet on cholesterol drug
Biopharma Dive
Sun, 11/24/19 - 11:38 pm
Novartis
The Medicines Company
M&A
BMS investors bet big on 3 newly acquired Celgene drugs for cancer and MS
Fierce Pharma
Sun, 11/24/19 - 11:35 pm
Bristol-Myers Squibb
Celgene
M&A
ozanimod
liso-cel
bb2121
Does Amarin Have a Dark Horse Suitor?
Motley Fool
Sun, 11/24/19 - 11:32 pm
Amarin
Vascepa
M&A
Gilead Sciences
Put on hold music: Roche delays Spark buyout for the 9th — and quite possibly not the last — time
Endpoints
Fri, 11/22/19 - 10:37 am
Roche
M&A
Spark Therapeutics
Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival
Stat
Fri, 11/22/19 - 10:00 am
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
Merck
M&A
AbbVie Shareholders Have a Lot to Look Forward To With Allergan
Motley Fool
Thu, 11/21/19 - 06:28 pm
AbbVie
Allergan
earnings
M&A
Hologic burns its aesthetics unit
EP Vantage
Thu, 11/21/19 - 10:43 am
devices
medical aesthetics
M&A
Hologic
Cynosure
Sanofi weighing options for consumer healthcare unit: sources
Reuters
Thu, 11/21/19 - 10:37 am
Sanofi
consumer healthcare
M&A
Bristol-Myers Squibb completes $74bn acquisition of biotechnology firm Celgene
Pharmaceutical Business Review
Thu, 11/21/19 - 10:14 am
M&A
Bristol-Myers Squibb
Celgene
Gilead CEO Daniel O'Day says company is in an 'acquisitive mode'
Stat
Wed, 11/20/19 - 10:43 pm
Gilead Sciences
Daniel O'Day
Pharma CEOs
M&A
Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.
Motley Fool
Wed, 11/20/19 - 10:02 am
Amarin
Vascepa
M&A
Amgen
Novartis
Pfizer
Amidst Novartis Takeover Rumors, The Medicines Company Announces Positive Cholesterol Data
BioSpace
Tue, 11/19/19 - 11:32 pm
The Medicines Company
Novartis
M&A
inclisiran
clinical trials
Novartis eyes Medicines Co to boost cardio franchise - report
Yahoo/Reuters
Tue, 11/19/19 - 10:18 am
Novartis
The Medicines Company
cardiovascular disease
M&A
Aerie Pharmaceuticals agrees to acquire Avizorex Pharma
Pharmaceutical Business Review
Tue, 11/19/19 - 09:59 am
Aerie Pharmaceuticals
Avizorex Pharma
M&A
ophthalmic
dry eye disease
Alkermes To Acquire Rodin Therapeutics
NASDAQ
Mon, 11/18/19 - 09:58 am
Alkermes
Rodin Therapeutics
M&A
CNS
Bristol-Celgene Merger Leaps FTC Clearance; Deal Set To Close Wednesday
Investors Business Daily
Sat, 11/16/19 - 10:30 pm
Bristol-Myers Squibb
Celgene
FTC
M&A
Roche buys U.S. drugmaker Promedior for up to $1.4 billion to get lung drug
Reuters
Sat, 11/16/19 - 12:01 am
Roche
Promedior
idiopathic pulmonary fibrosis
M&A
Thermo Fisher Rumored to Be Interested in Acquiring Qiagen
Medical Devices and Diagnostics Industry
Fri, 11/15/19 - 11:58 pm
devices
Thermo Fisher
Qiagen
M&A

Pages